Accelerated Ovarian Aging Among Type 2 Diabetes Patients and Its Association With Adverse Lipid Profile

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Apr 18

PMID 35432199

Authors

Yahao Wang

Yangang Wang

Affiliations

Soon will be listed here.

Abstract

Background: The impact of diabetes on reproductive function is still not clearly defined. This study aimed to evaluate accelerated ovarian aging in women with type 2 diabetes mellitus (T2DM) and its association with adverse lipid profile.

Methods: Female patients with T2DM (n=964) and non-T2DM controls (n=263) aging from 18-80 years were included. Levels of circulating sex hormones were measured at the follicular phase in menstruating women. We analyzed the age-specific trends in the levels of sex hormones between T2DM and controls. The correlations of sex hormones with the lipid profile, including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides (TG) were also evaluated.

Results: In the temporal trends analysis, LH and FSH both started to increase obviously approximately from the age of 45 years among patients with T2DM, and displayed peaks of LH and FSH among patients with T2DM aged between 61 and 65, both of which were obviously earlier than that in non-T2DM controls and proved the accelerated ovarian aging among patients with T2DM. E2 of patients with T2DM was continuous lower than that of non-T2DM controls from approximately 45 years old, and LH and FSH of patients with T2DM were higher than those of non-T2DM controls between the age of 55 to 65 years. Multiple linear regression analyses revealed that LH was positively correlated with LDL-C (Coefficient=0.156, P=0.001) and TC (Coefficient=0.134, P=0.025), and was negatively correlated with HDL-C (Coefficient =-0.065, P=0.001) in patients with T2DM aged between 51 and 60, which was independent of age, T2DM duration, body mass index (BMI), glycosylated hemoglobin (HbA1c), FSH, E2 and other potential confounders. Higher E2 level was significantly and independently correlated with lower LDL-C (Coefficient= -0.064, P=0.033) in patients with T2DM aged between 51 and 60.

Conclusions: This study suggests that patients with T2DM have accelerated ovarian aging, and it is correlated with the occurrence of disturbed lipid profile in patients with T2DM. With an ever increasing number of female patients with T2DM diagnosed at younger ages, the accelerated ovarian aging and its adverse impacts in T2DM need to be carefully managed.

Citing Articles

Unraveling the Link: A Comprehensive Literature Review of Type 2 Diabetes and Menopause Onset.

Mohile A, Hedaoo R, Jadhav S, Ainapure A, Patil M, Khatwani N Cureus. 2024; 15(12):e50743.

PMID: 38234930 PMC: 10794094. DOI: 10.7759/cureus.50743.

miR-143-3p Promotes Ovarian Granulosa Cell Senescence and Inhibits Estradiol Synthesis by Targeting UBE2E3 and LHCGR.

Deng J, Tang Y, Li L, Huang R, Wang Z, Ye T Int J Mol Sci. 2023; 24(16).

PMID: 37628741 PMC: 10454865. DOI: 10.3390/ijms241612560.

Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy.

Matou-Nasri S, Aldawood M, Alanazi F, Khan A Diagnostics (Basel). 2023; 13(14).

PMID: 37510134 PMC: 10378597. DOI: 10.3390/diagnostics13142390.

Sex differences in the non-linear association between BMI and LDL cholesterol in type 2 diabetes.

Li K, Cao B, Wang X, Chai T, Ke J, Zhao D Front Endocrinol (Lausanne). 2023; 14:1180012.

PMID: 37484947 PMC: 10360932. DOI: 10.3389/fendo.2023.1180012.

Female obesity and infertility: outcomes and regulatory guidance.

Marinelli S, Napoletano G, Straccamore M, Basile G Acta Biomed. 2022; 93(4):e2022278.

PMID: 36043953 PMC: 9534231. DOI: 10.23750/abm.v93i4.13466.

References

Munir J, Wu H, Bauer K, Bindeman J, Byrd C, Feuerstein I . The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels. Menopause. 2011; 19(1):10-5. DOI: 10.1097/gme.0b013e318221bc8d. View

Briley S, Jasti S, McCracken J, Hornick J, Fegley B, Pritchard M . Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction. 2016; 152(3):245-260. PMC: 4979755. DOI: 10.1530/REP-16-0129. View

Wang Q, Santos Ferreira D, Nelson S, Sattar N, Ala-Korpela M, Lawlor D . Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med. 2018; 16(1):17. PMC: 5800033. DOI: 10.1186/s12916-018-1008-8. View

Chatterjee S, Khunti K, Davies M . Type 2 diabetes. Lancet. 2017; 389(10085):2239-2251. DOI: 10.1016/S0140-6736(17)30058-2. View

Hasan Sohel M, Akyuz B, Konca Y, Arslan K, Sariozkan S, Cinar M . Oxidative stress modulates the expression of apoptosis-associated microRNAs in bovine granulosa cells in vitro. Cell Tissue Res. 2019; 376(2):295-308. DOI: 10.1007/s00441-019-02990-3. View

Das M, Sauceda C, Webster N . Mitochondrial Dysfunction in Obesity and Reproduction. Endocrinology. 2020; 162(1). PMC: 7709214. DOI: 10.1210/endocr/bqaa158. View

Bertone-Johnson E, Virtanen J, Nurmi T, Niskanen L, Mursu J, Voutilainen S . Follicle-Stimulating Hormone Levels and Subclinical Atherosclerosis in Older Postmenopausal Women. Am J Epidemiol. 2018; 187(1):16-26. DOI: 10.1093/aje/kwx174. View

El Khoudary S, Wildman R, Matthews K, Thurston R, Bromberger J, Sutton-Tyrrell K . Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition. Atherosclerosis. 2012; 225(1):180-6. PMC: 3478422. DOI: 10.1016/j.atherosclerosis.2012.07.025. View

Yi Y, El Khoudary S, Buchanich J, Miller R, Rubinstein D, Orchard T . Association of age at diabetes complication diagnosis with age at natural menopause in women with type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications. 2021; 35(3):107832. PMC: 7870550. DOI: 10.1016/j.jdiacomp.2020.107832. View

10.

Snider A, Wood J . Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019; 158(3):R79-R90. DOI: 10.1530/REP-18-0583. View

11.

Lascar N, Brown J, Pattison H, Barnett A, Bailey C, Bellary S . Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2017; 6(1):69-80. DOI: 10.1016/S2213-8587(17)30186-9. View

12.

South S, Asplin C, Carlsen E, Booth Jr R, Weltman J, Johnson M . Alterations in luteinizing hormone secretory activity in women with insulin-dependent diabetes mellitus and secondary amenorrhea. J Clin Endocrinol Metab. 1993; 76(4):1048-53. DOI: 10.1210/jcem.76.4.8473380. View

13.

Yang Z, Tang Z, Cao X, Xie Q, Hu C, Zhong Z . Controlling chronic low-grade inflammation to improve follicle development and survival. Am J Reprod Immunol. 2020; 84(2):e13265. DOI: 10.1111/aji.13265. View

14.

Lopez-Lopez R, Huerta R, Malacara J . Age at menopause in women with type 2 diabetes mellitus. Menopause. 1999; 6(2):174-8. View

15.

Schnatz P, Jiang X, Aragaki A, Nudy M, OSullivan D, Williams M . Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial. Obstet Gynecol. 2016; 129(1):121-129. PMC: 5177479. DOI: 10.1097/AOG.0000000000001774. View

16.

Roelfsema F, Yang R, Veldhuis J . Differential Effects of Estradiol and Progesterone on Cardiovascular Risk Factors in Postmenopausal Women. J Endocr Soc. 2018; 2(7):794-805. PMC: 6030831. DOI: 10.1210/js.2018-00073. View

17.

Garris D, Garris B . Diabetes (db/db) mutation-induced ovarian involution: progressive hypercytolipidemia. Exp Biol Med (Maywood). 2003; 228(9):1040-50. DOI: 10.1177/153537020322800909. View

18.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y . Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic.... Diabetes Obes Metab. 2018; 21(4):791-800. PMC: 6587486. DOI: 10.1111/dom.13575. View

19.

Cho K, Yu J, Hayashi T, Han S, Kon Koh K . Strategies to Overcome Residual Risk During Statins Era. Circ J. 2019; 83(10):1973-1979. DOI: 10.1253/circj.CJ-19-0624. View

20.

Soto N, Iniguez G, Lopez P, Larenas G, Mujica V, Rey R . Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod. 2009; 24(11):2838-44. DOI: 10.1093/humrep/dep276. View